Advertisement

Topics

Kowa Pharmaceuticals America, Inc. Company Profile

17:36 EDT 28th April 2017 | BioPortfolio

About Kowa Company, Ltd. and Kowa Pharmaceuticals America, Inc.


News Articles [1375 Associated News Articles listed on BioPortfolio]

Kowa Pharma Granted Exclusive U.S. Rights to Gout Compound

NewsKowa Pharmaceuticals America, Inc. announces agreement with CymaBay Therapeutics to license gout compound. Kowa Pharma Licenses CymaBay to Market Gout Compound

Kowa Pharmaceuticals America, Inc., formerly ProEthic Pharmaceuticals, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350

Project Synopsis:Datamonitor's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken...

CymaBay, Kowa Pharma America Form Pact

Kowa to fully fund development through NDA of arhalofenate in the U.S.

CymaBay licenses Kowa US rights to late-stage gout candidate

CymaBay Therapeutics Inc. licensed Kowa Pharmaceuticals America Inc. exclusive rights to develop and commercialize its Phase III-ready gout candidate arhalofenate in the US. (CymaBay retains all right...

BRIEF-Kowa Pharmaceuticals enters agreement with CymaBay Therapeutics to license gout compound

* Kowa Pharmaceuticals America Inc announces agreement with CymaBay Therapeutics to license gout compound

Livalo Superior to Pravastatin in Lowering LDL Cholesterol for HIV Patients

NewsKowa Pharmaceuticals America, Inc. announces INTREPID trial results in The Lancet HIV showing superior LDL cholesterol reduction with Livalo (pitavastatin) compared with pravastatin in adults with...

CymaBay Announces Exclusive Licensing Agreement with Kowa Pharmaceuticals America, Inc. for the Development and Commercialization of Arhalofenate in the United States

— Kowa to fully fund development through NDA approval— CymaBay to receive up to $205M in up-front and milestone payments— Conference call and webcast today at 4:30 pm ET NEWARK, Calif., Jan...

Kowa Pharmaceuticals America Announces Agreement With CymaBay Therapeutics To License Gout Compound

  Life Sciences Jobs   ...

Drugs and Medications [495 Associated Drugs and Medications listed on BioPortfolio]

Antimicrobial [Safetec of America]

Antimicrobial

A.b.h.c. instant hand sanitizer citrus scent [Safetec of America, Inc.]

A.B.H.C. INSTANT HAND SANITIZER

Hydrocortisone [Safetec of America, Inc.]

Safetec First Aid 1% Hydrocortisone Cream

Analgesic [Safetec of America, Inc.]

Safetec of America, Inc. PAIN SPRAY

Antiseptic [Safetec of America]

ANTISEPTIC – Benzalkonium chloride liquid Safetec of America

PubMed Articles [752 Associated PubMed Articles listed on BioPortfolio]

Progress Confirmed for Pharmaceuticals in 2016.

n/a.

Letter--The Authors Respond.

None of the authors of this study are involved in financial or personal relationships with agencies, institutions, or organizations that inappropriately influenced the statistical analysis plan or int...

Temporal and spatial behavior of pharmaceuticals in Narragansett Bay, Rhode Island, United States.

The behavior and fate of pharmaceutical ingredients in coastal marine ecosystems is not well understood. To address this, the spatial and temporal distribution of 15 high volume pharmaceuticals were m...

Estimation of amount of selected pharmaceuticals sorbed onto digested sludge from wastewater treatment plant Bratislava-Petržalka.

Antibiotics and antidepressants are among the most successful drugs used for human therapy. Their concentration in influent on WWTP is relative high and there can be removed by biodegradation or sorpt...

Status of pharmaceuticals in African water bodies: Occurrence, removal and analytical methods.

In this review paper, the milestones and challenges that have been achieved and experienced by African Environmental Scientists regarding the assessment of water pollution caused by the presence of ph...

Clinical Trials [470 Associated Clinical Trials listed on BioPortfolio]

A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Dexlansoprazole from Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis

This is a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Pimecrolimus Cream, 1% (Glenmark Pharmaceut...

Improving Perinatal Care in Latin America

Many obstetrical interventions used in Latin America, as in other parts of the world, have been shown to be ineffective or harmful, while effective interventions remain underutilized. This...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Companies [2127 Associated Companies listed on BioPortfolio]

Kowa Company Ltd., Kowa Pharmaceuticals America, Inc., and Kowa Research Institute, Inc.

Kowa Company Ltd. and Kowa Pharmaceuticals America, Inc.

Kowa Company, Ltd. is a privately held multinational company headquartered in Nagoya, Japan. Established in 1894, Kowa is actively engaged in various manufacturing and trading activities in the fields...

Kowa Research Institute, Inc

Kowa Research Institute, Inc. located in the RTP area of North Carolina is responsible for the clinical development of Kowa Company’s new drugs in the United States. Kowa Research Institute, Inc. i...

Kowa Pharmaceuticals America, Inc.

About Kowa Company, Ltd. and Kowa Pharmaceuticals America, Inc.

Kowa Company, Ltd.

Kowa Company, Ltd. (Headquarters: Nagoya, Japan , President & CEO: Yoshihiro Miwa, "Kowa") is a privately held multinational company headquartered in Nagoya, Japan. Established in...

More Information about "Kowa Pharmaceuticals America, Inc." on BioPortfolio

We have published hundreds of Kowa Pharmaceuticals America, Inc. news stories on BioPortfolio along with dozens of Kowa Pharmaceuticals America, Inc. Clinical Trials and PubMed Articles about Kowa Pharmaceuticals America, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Kowa Pharmaceuticals America, Inc. Companies in our database. You can also find out about relevant Kowa Pharmaceuticals America, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record